YAP1 and melanoma: Here, we found YAP and TAZ to be expressed at variable levels in melanoma (Supplementary Fig. 3i, j) and that siRNA targeted inhibition of YAP, TAZ, and YAP/TAZ decrease VM formation in Cl.2A and YUSIK cells (Supplementary Fig. 6).